Managing Chemotherapy-Induced Nausea and Vomiting (CINV) to Improve Patient Care

Pharmacy Practice in Focus: Health SystemsSeptember 2017
Volume 6
Issue 5

This activity is supported by educational grants from Eisai Inc. and Tesaro, Inc.

Managing Chemotherapy-Induced Nausea and Vomiting (CINV) to Improve Patient Care


Sally Yowell Barbour, PharmD, BCOP, CPP, FHOPA

Director of Oncology Pharmacy ProgramsDuke University Medical Center Durham, North Carolina

Patrick Medina, PharmDProfessor of Medicine Stephenson Cancer Center University of Oklahoma Oklahoma City, Oklahoma

Medical Writers

Thomas J. Cook, PhD, RPhFreelance Medical Writer Stewartsville, New JerseyJoanne FaysalMedical WriterSouth Palm Beach, Florida

Educational Objective

At the completion of this activity, the participant will be able to:

  • Discuss pharmacologic treatment options to manage chemotherapy-induced nausea and vomiting (CINV)
  • Identify appropriate monitoring parameters based on chemotherapy and CINV regimen
  • Apply safety and efficacy data when evaluating CINV agents

Target Audience: Pharmacists and pharmacy directors ACTIVITY TYPE: Application

Release Date: September 12, 2017

Expiration Date: September 12, 2018

Estimated Time to Complete Activity: 2.0 hours

Fee: This lesson is offered for free at

Pharmacy Times Continuing EducationTM is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.20 CEUs) under the ACPE universal activity number 0290-0000-17-143-H01-P. The activity is available for CE credit through Sept. 12, 2018.

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs
© 2024 MJH Life Sciences

All rights reserved.